Protalix BioTherapeutics
PLX
PLX
36 hedge funds and large institutions have $4.63M invested in Protalix BioTherapeutics in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Holders
36
Holding in Top 10
–
Calls
$85K
Puts
–
Top Buyers
| 1 | +$1.21M | |
| 2 | +$75K | |
| 3 | +$17K | |
| 4 |
Bank of New York Mellon
New York
|
+$8K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$6.32K |
Top Sellers
| 1 | -$2.72M | |
| 2 | -$1.14M | |
| 3 | -$71.3K | |
| 4 |
BlackRock
New York
|
-$55K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$25K |